Developing innovations to be sold or out licensed with high returns
Most investors find it difficult to evaluate bioscience inventions. But we do this on your behalf through our long experience of turning life science inventions into viable business opportunities.The objective is to create value for investors, inventors and also society by developing innovations into projects/products to be sold or out licensed with high returns.
All LU Bio portfolio companies are developing drugs based on a first or best-in-class concept, which addresses unmet medical needs in commercially attractive segments. All development activities are tailored to provide potential partners or buyers sufficient data to enable business deals already during the late pre-clinical stage.
Together with our network of experts we are geared up to develop our different portfolio companies to spread the investment risk for the benefit of investors. LU Bio primarily invests in three types of inventions or companies:
With our well-developed bioscience network, we also strive to achieve synergies that can be created together with inventions from other innovation systems.
You can contact us here